-transparent.png){kind=logo}
Methylmercuric chloride (MMC) in concentrations 0.1-10 microM reduces the amount of fibrinopeptides released from thrombin-activated human fibrinogen. However, the fibrin clot formation is not discriminated and the turbidity of the fibrin gel is even augmented. MMC does not cause such changes in the process of repolymerization of fibrin monomers. The addition of fibrinopeptides to the fibrin monomers results in a similar increase of turbidity of the repolymerizing sample in the presence of MMC as in the case of fibrinogen clotting. These experiments indicate that MMC modifies the structure of fibrin in the presence of fibrinopeptides.
Related Publications
M Michalska, and
R Wierzbicki
September 1996,
Gan to kagaku ryoho. Cancer & chemotherapy,
M Michalska, and
R Wierzbicki
January 1959,
Texas reports on biology and medicine,
M Michalska, and
R Wierzbicki
September 1983,
Lipids,
M Michalska, and
R Wierzbicki
August 1984,
Prostaglandins, leukotrienes, and medicine,
M Michalska, and
R Wierzbicki
July 1982,
Archives of toxicology,
M Michalska, and
R Wierzbicki
April 1986,
Journal of pharmacobio-dynamics,
M Michalska, and
R Wierzbicki
September 1976,
The Kumamoto medical journal,
M Michalska, and
R Wierzbicki
October 1976,
Igaku kenkyu. Acta medica,
M Michalska, and
R Wierzbicki
January 1972,
Annual report of the Research Institute of Environmental Medicine, Nagoya University,
M Michalska, and
R Wierzbicki
August 1984,
Okajimas folia anatomica Japonica,
